esmodafinil also known smodafinil modafinil enantiopure isolation enantiomer modafinil unlike armodafinil esmodafinil never marketed esmodafinil suspected less clinically useful treating conditions modafinil armodafinil marketed narcolepsy sleepshift work disorder obstructive sleep esmodafinil possesses substantially shorter half life hours compared armodafinil esmodafinil times lower affinity dopamine transporter compared enantiomers modafinil preferentially bind dopamine transporter inward facing esmodafinil researched treatment cocaine like armodafinil esmodafinil attenuates effects cocaine occupying dopamine esmodafinil increases dopamine nucleus accumbens lesser extent however short halflife esmodafinil cited reason investigate armodafinil cocaine addiction treatment modafinil considered stimulant doping agent prohibited world antidoping agency sports validated methods researched separately quantify modafinil enantiomers real httpsenwikipediaorgwikiesmodafinil